Patented technology that transforms key inflammatory messengers from agents of destruction to agents of repair
Enables you to alter patients’ disease progression and put them on the path to healing
Seamlessly integrates into your critical-care workflow so you won’t miss a beat
Critically ill patients in the throes of a cytokine storm are facing an alarming, urgent situation. That’s because this dangerous, dysregulated hyperinflammatory response can cause multiorgan damage and in severe cases, death.
SeaStar Medical is an innovator with groundbreaking solutions that give you the power to stop this serious threat before it can do irreparable harm to the patients you are fighting for.
Backed by rigorous clinical research and robust scientific evidence, our patented approach is designed to support your clinical end goals including reducing dialysis dependency, improving outcomes, and saving precious lives.
COVID-19, acute respiratory distress syndrome, acute kidney injury, and many other health issues can result in a dangerous cytokine storm. With SeaStar Medical’s novel, simple-to-use SCD cell-directed extracorporeal therapy, you can quickly rescue patients from a cytokine storm, regardless of how it was triggered, and restore reparative functionality to the body and potentially reverse injury.
The SCD is an investigational device and is not currently available for sale. Please check back for further updates on device availability in your region.
Representative product illustration; product subject to future changes.
A shorter treatment regimen to reach the desired effect may reduce dependency on dialysis and time in the ICU. This can help put patients on the road back to recovery sooner and free up resources more quickly.